Sysplatt A 75 Tabs
Product Details
Sysplatt A 75 Tablet combines Aspirin 75mg and Clopidogrel 75mg, two proven medicines for cardiovascular protection. It is widely prescribed to prevent heart attacks, strokes, and blood clot formation. The dual-action formula works by preventing platelet aggregation and reducing inflammation, helping maintain healthy blood flow in at-risk patients.
Key Features
- Combines Aspirin 75mg and Clopidogrel 75mg
- Reduces risk of heart attack, stroke, and clot-related conditions
- Provides dual antiplatelet protection for high-risk individuals
- Maintains smooth blood circulation by preventing clot formation
- Suitable for patients post-angioplasty or with existing heart disease
- Helps manage both inflammatory and clotting risks
Enquiry Now
We’re Open to Serve You
- Monday – Friday: 9:00 AM – 7:00 PM
- Saturday : 9:00 AM – 6:00 PM
- Sunday: Closed
Sysplatt A 75 Tablet is a combination medication containing Aspirin (75mg) and Clopidogrel (75mg). This dual antiplatelet therapy is prescribed to reduce the risk of heart attacks, strokes, and other cardiovascular complications in people who are prone to blood clots or have established heart disease. Aspirin acts by inhibiting the enzymes responsible for pain, fever, and inflammation, while Clopidogrel works by preventing platelets from clumping together, reducing the likelihood of clot formation within arteries.
Together, they provide a synergistic effect, offering superior protection against blood clots and maintaining smooth blood flow through arteries. Sysplatt A 75 is often recommended after stent placements, bypass surgeries, or episodes of acute coronary syndrome. This combination is especially effective for individuals with multiple risk factors like diabetes, hypertension, and previous cardiac events. Regular use under medical supervision ensures effective prevention of serious cardiovascular events and supports long-term heart health.
- Prevention of heart attack
- Prevention of stroke
- Post-angioplasty or stent placement care
- Peripheral arterial disease management
- Treatment of acute coronary syndrome
- Reducing blood clot formation
- Prevention of complications in high-risk diabetic patients
- Management of rheumatic or musculoskeletal pain (Aspirin role)
- Prevention of recurrent ischemic events
- Adjunct therapy with statins and beta-blockers in heart patients
Sysplatt A 75 Tablet works through the combined actions of Aspirin and Clopidogrel. Aspirin, an NSAID, acts by irreversibly inhibiting cyclooxygenase (COX) enzymes, which are responsible for producing prostaglandins that cause pain, fever, and inflammation. In the context of cardiovascular protection, Aspirin helps by reducing the formation of thromboxane A2, a substance that promotes platelet aggregation and constriction of blood vessels.
On the other hand, Clopidogrel works by blocking the P2Y12 ADP receptor on platelets, preventing them from sticking together and forming dangerous clots. This dual mechanism ensures comprehensive protection by both reducing inflammation and preventing platelet aggregation, two key factors in cardiovascular events. This combination is highly effective in patients with existing cardiovascular diseases or those who have undergone angioplasty or bypass surgery. Sysplatt A 75 helps maintain healthy blood flow and significantly lowers the risk of future heart attacks and strokes when taken as prescribed.